A recent study shows that combining magnetic brain scans with computer models can safely measure how dementia medications affect living human brains. This approach could replace invasive tests and ...
Cognition Therapeutics, Inc., (the 'Company” or 'Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, presented an analysis from the Phase 2 ...
Kidney Disease,” an editorially independent special report that was produced with financial support from Vertex. M ore than one in sev ...
A series of novel treatments and medical insights is helping chronic kidney disease patients This article is part of ...
MedPage Today on MSN
An Alzheimer's revolution is coming, experts say
Research roundtable highlights early detection, biomarkers, interventions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results